Similar articles for PMID: 28798227

1

Cite

Share

⁶⁸Ga-DOTATATE PET/CT Can Be an Alternative Imaging Method in Insulinoma Patients.

Tuzcu SA, Pekkolay Z, Kılınç F, Tuzcu AK. Tuzcu SA, et al. J Nucl Med Technol. 2017 Sep;45(3):198-200. doi: 10.2967/jnmt.117.192708. Epub 2017 Aug 10. J Nucl Med Technol. 2017. PMID: 28798227 Free article.

Cite

Share

2

Cite

Share

Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan.

Nockel P, Babic B, Millo C, Herscovitch P, Patel D, Nilubol N, Sadowski SM, Cochran C, Gorden P, Kebebew E. Nockel P, et al. J Clin Endocrinol Metab. 2017 Jan 1;102(1):195-199. doi: 10.1210/jc.2016-3445. J Clin Endocrinol Metab. 2017. PMID: 27805844 Free PMC article.

Cite

Share

3

Cite

Share

Volume Replacement Fluid Demarks Benign Insulinoma With 68Ga-DOTA-Exendin-4 PET/CT.

Antwi K, Nicolas G, Fani M, Christ E, Wild D. Antwi K, et al. Clin Nucl Med. 2019 May;44(5):e347-e348. doi: 10.1097/RLU.0000000000002522. Clin Nucl Med. 2019. PMID: 30889001

Cite

Share

4

Cite

Share

Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.

Deppen SA, Liu E, Blume JD, Clanton J, Shi C, Jones-Jackson LB, Lakhani V, Baum RP, Berlin J, Smith GT, Graham M, Sandler MP, Delbeke D, Walker RC. Deppen SA, et al. J Nucl Med. 2016 May;57(5):708-14. doi: 10.2967/jnumed.115.163865. Epub 2016 Jan 14. J Nucl Med. 2016. PMID: 26769865 Free PMC article.

Cite

Share

5

Cite

Share

68Ga DOTA-Exendin PET/CT for Detection of Insulinoma in a Patient With Persistent Hyperinsulinemic Hypoglycemia.

Parihar AS, Vadi SK, Kumar R, Mittal BR, Singh H, Bal A, Walia R, Shukla J, Sinha SK. Parihar AS, et al. Clin Nucl Med. 2018 Aug;43(8):e285-e286. doi: 10.1097/RLU.0000000000002155. Clin Nucl Med. 2018. PMID: 29877881

Cite

Share

6

Cite

Share

68Ga-Exendin-4 PET/CT Detects Insulinomas in Patients With Endogenous Hyperinsulinemic Hypoglycemia in MEN-1.

Antwi K, Nicolas G, Fani M, Heye T, Pattou F, Grossman A, Chanson P, Reubi JC, Perren A, Gloor B, Vogt DR, Wild D, Christ E. Antwi K, et al. J Clin Endocrinol Metab. 2019 Dec 1;104(12):5843-5852. doi: 10.1210/jc.2018-02754. J Clin Endocrinol Metab. 2019. PMID: 31298706 Free article.

Cite

Share

7

Cite

Share

Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.

Kauhanen S, Seppänen M, Minn H, Gullichsen R, Salonen A, Alanen K, Parkkola R, Solin O, Bergman J, Sane T, Salmi J, Välimäki M, Nuutila P. Kauhanen S, et al. J Clin Endocrinol Metab. 2007 Apr;92(4):1237-44. doi: 10.1210/jc.2006-1479. Epub 2007 Jan 16. J Clin Endocrinol Metab. 2007. PMID: 17227804

Cite

Share

8

Cite

Share

Detection of insulinoma using (68)Gallium-DOTATATE PET/CT: a case report.

Sadowski SM, Neychev V, Cottle-Delisle C, Merkel R, Yang LA, Quezado MM, Chang R, Kebebew E. Sadowski SM, et al. Gland Surg. 2014 Nov;3(4):E1-5. doi: 10.3978/j.issn.2227-684X.2014.10.02. Gland Surg. 2014. PMID: 25493261 Free PMC article.

Cite

Share

9

Cite

Share

Malignant insulinoma: 18F-DOPA and 68Ga-DOTATATE PET/CT and treatment with 177Lu-DOTATATE.

Erhamamcı S, Sager S, Asa S, Uslu L, Akgun E, Sonmezoglu K. Erhamamcı S, et al. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Nov-Dec;39(6):383-386. doi: 10.1016/j.remn.2019.12.002. Epub 2020 May 30. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020. PMID: 32487444 English, Spanish. No abstract available.

Cite

Share

10

Cite

Share

Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.

Sadowski SM, Neychev V, Millo C, Shih J, Nilubol N, Herscovitch P, Pacak K, Marx SJ, Kebebew E. Sadowski SM, et al. J Clin Oncol. 2016 Feb 20;34(6):588-96. doi: 10.1200/JCO.2015.64.0987. Epub 2015 Dec 28. J Clin Oncol. 2016. PMID: 26712231 Free PMC article.

Cite

Share